Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
a.k.a. subacute necrotizing encephalomyelopathy
Genetically heterogeneous mitochondrial disorder characterized by progressive neurodegeneration
Best imaging: MR with DWI/MRS
Bilateral, symmetric ↑ T2/FLAIR corpora striata (putamen > caudate) > globi pallidi, periaqueductal gray matter, substantia nigra/subthalamic nuclei, dorsal pons, cerebellar nuclei
Reduced diffusion in regions of acute disease
Lactate peak often present on MRS; may be large
Uncommon appearance: Predominant white matter disease (simulates leukodystrophy)
Profound perinatal asphyxia
Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS)
Glutaric aciduria type 1
Wilson disease
Bioenergetic failure (ATP loss) and production of reactive oxygen species likely key factors in mitochondria-mediated cell apoptosis
50-75% of patients with Leigh syndrome have detectable biochemical or molecular abnormality
Presentation
Psychomotor delay/regression, dystonia/hypotonia, ataxia
Other: Ophthalmoplegia, seizures, lactic acidosis
Prenatal diagnosis: Chorionic villus sampling (mutations and biochemical defects)
Majority present by age 2 years
Leigh syndrome (LS)
Subacute necrotizing encephalomyelopathy
Genetically heterogeneous mitochondrial disorder characterized by progressive neurodegeneration
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here